Applied Therapeutics, Inc. 4/A SEC Filings

Filed On	Filing
16 Sep 2022	Form 4/A: Marcus Joel S, Director Received 48,982 shares by exercise or conversion ($299K)
11 Jan 2022	Form 4/A: Silberstein Charles, Chief Financial Officer Received 47,900 shares as a grant or award
11 Jan 2022	Form 4/A: Shendelman Shoshana, Director Received 120,900 shares as a grant or award
11 Jan 2022	Form 4/A: Perfetti Riccardo, Chief Medical Officer Received 48,200 shares as a grant or award
11 Jan 2022	Form 4/A: Hansard Adam, Chief Commercial Officer Received 31,700 shares as a grant or award
29 May 2019	Form 4/A: Shendelman Shoshana, Director Received 88,397 shares by conversion

Comments